MedTrace Logo

Universal Ultrasound-screening for Developmental Dysplasia of the Hip in Newborn

NCT01053299 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4200

Last updated 2010-01-28

No results posted yet for this study

Summary

All newborn from the period 12.1988 to 31.12.2006 During the two last decades, hip ultrasound has gained acceptance as an accurate screening test for developmental dysplasia of the hip (DDH) and for monitoring the development and treatment of the condition. Debate continues over whether DDH that is detected by ultrasonography is necessarily clinically relevant. The diagnostic accuracy of ultrasound imaging for DDH in the screening population has not been investigated adequately. Studies that investigate the natural course of the disorder, the optimal treatment for DDH, and the best strategy for ultrasound screening are needed. Ultrasound screening at birth for DDH in all newborn infants is standard practice in some European countries but not in the United Kingdom, the United States, or Scandinavia. Evidence is insufficient to support or reject general ultrasound screening of newborns for DDH. (N.F.Woolacott etc 2006, systematic review BMJ) At Vestre Viken HF, Kongsberg, Norway, the investigators implemented universal ultrasound screening in 1998. We will present the long term outcome, including radiographs of the hips after 5-12 years.

Conditions

  • Developmental Dysplasia of the Hip (DDH)

Interventions

OTHER

open, prospective cohort-study

Specific measurements from the X-ray to assess the hip status 5-12 years from the born.

Sponsors & Collaborators

  • Vestre VikenHF Kongsberg Sykehus

    lead OTHER

Principal Investigators

  • Erlend Skraastad, MD · Vestre Viken HF

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053299 on ClinicalTrials.gov